Catalent Stock: Charting A Post-Covid Future (NYSE:CTLT)
seekingalpha.com
news
2022-10-19 09:09:08

Tingting Ji/iStock via Getty Images Not all bees are loyal to the same hive. â€• Marty Rubin Today, we take a look at Catalent, Inc. (NYSE:CTLT) for the first time. This diversified supplier of Biologics, healthcare and pharma products has maintained analyst firm enthusiasm despite a forward guidance cut at its last quarterly earnings report. The company is delivering steady organic sales growth in an uncertain market environment. With the stock down just over 40% over the past year, is this equity in the 'buy zone' yet? An analysis follows below.
